Projects per year
Personal profile
Keywords
- Interstitial lung disease
Projects 2017 2022
- 6 Active
A Randomized Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis (ATLAS Study)
Glaspole, I. & Symons, K. M.
7/06/19 → 1/06/22
Project: Research
Clinical and biological approaches to improving diagnostic confidence of Chronic Hypersensitivity Pneumonitis.
Glaspole, I. & Barnes, H.
4/03/19 → 3/03/22
Project: Research
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BG00011 in Patients with Idiopathic Pulmonary Fibrosis.
Glaspole, I. & Symons, K. M.
13/09/18 → 31/07/22
Project: Research
Circulatory biomarkers for Idiopathic Pulmonary Fibrosis: improving patient outcomes
Moodley, Y., Corte, T. J., Knight, D., Reynolds, P., Walters, E. H., Glaspole, I., Baltic, S., Sohal, S. & Grainge, C.
National Health & Medical Research Council (NHMRC)
1/01/18 → 31/12/20
Project: Research
Ambulatory oxygen for interstitial lung disease
Holland, A. E., McDonald, C. F., Corte, T. J., Chambers, D., Palmer, A. J., Ekström, M., Glaspole, I., Goh, N. S. & Hepworth, G.
1/01/18 → 31/12/22
Project: Research
Research Output 1997 2019
Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
Jo, H. E., Glaspole, I., Goh, N., Hopkins, P. M. A., Moodley, Y., Reynolds, P. N., Chapman, S., Walters, E. H., Zappala, C., Allan, H., Macansh, S., Grainge, C., Keir, G. J., Hayen, A., Henderson, D., Klebe, S., Heinze, S. B., Miller, A., Rouse, H. C., Duhig, E. & 7 others, 1 Apr 2019, In : Respirology. 24, 4, p. 361-368 8 p.Research output: Contribution to journal › Article › Research › peer-review
A phase 2 randomized controlled study of tralokinumab in subjects with idiopathic pulmonary fibrosis
Parker, J. M., Glaspole, I. N., Lancaster, L. H., Haddad, T. J., She, D., Roseti, S. L., Fiening, J. P., Grant, E. P., Kell, C. M. & Flaherty, K. R., 1 Jan 2018, In : American Journal of Respiratory and Critical Care Medicine. 197, 1, p. 94-103 10 p.Research output: Contribution to journal › Article › Research › peer-review
Cyclophosphamide for connective tissue disease-associated interstitial lung disease (Review)
Barnes, H., Holland, A. E., Westall, G. P., Goh, N. S. L. & Glaspole, I. N., 3 Jan 2018, In : Cochrane Database of Systematic Reviews. 2018, 1, 57 p., CD010908.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access
File
Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic society of Australia and New Zealand and lung foundation australia position statements summary
Jo, H. E., Prasad, J. D., Troy, L. K., Mahar, A., Bleasel, J., Ellis, S. J., Chambers, D. C., Holland, A. E., Lake, F. R., Keir, G., Goh, N. S., Wilsher, M., de Boer, S., Moodley, Y., Grainge, C., Whitford, H. M., Chapman, S. A., Reynolds, P. N., Beatson, D., Jones, L. J. & 4 others, 5 Feb 2018, In : Medical Journal of Australia. 208, 2, p. 82-88 7 p.Research output: Contribution to journal › Article › Other › peer-review
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: Analysis from the Australian IPF registry
Jo, H. E., Glaspole, I., Moodley, Y., Chapman, S., Ellis, S., Goh, N., Hopkins, P., Keir, G., Mahar, A., Cooper, W., Reynolds, P., Haydn Walters, E., Zappala, C., Grainge, C., Allan, H., Macansh, S. & Corte, T. J., 25 Jan 2018, In : BMC Pulmonary Medicine. 18, 1, 8 p., 19.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File